BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11840153)

  • 1. Rituximab: enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphoma.
    Gisselbrecht C; Mounier N
    Semin Oncol; 2003 Feb; 30(1 Suppl 2):28-33. PubMed ID: 12652462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in the treatment of lymphoma with autologous transplantation.
    Moskowitz AJ; Moskowitz CH
    Oncologist; 2009 Sep; 14(9):921-9. PubMed ID: 19737999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ex vivo purging with CD34+ selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients.
    Jeon Y; Kim TY; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG
    Cytotherapy; 2023 Dec; 25(12):1307-1316. PubMed ID: 37542512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous Stem Cell Transplant in Hodgkin's and Non-Hodgkin's Lymphoma, Multiple Myeloma, and AL Amyloidosis.
    Alnasser SM; Alharbi KS; Almutairy AF; Almutairi SM; Alolayan AM
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hematopoietic stem cell transplant in the management of follicular lymphoma.
    Foster M; Gabriel DA; Shea T
    Oncologist; 2009 Jul; 14(7):726-38. PubMed ID: 19561292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study.
    Baech J; Husby S; Trab T; Kragholm K; Brown P; Gørløv JS; Jørgensen JM; Gudbrandsdottir S; Severinsen MT; Grønbaek K; Larsen TS; Wästerlid T; Eloranta S; Smeland KB; Jakobsen LH; El-Galaly TC
    Br J Haematol; 2024 Mar; 204(3):967-975. PubMed ID: 38155503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of follicular non-Hodgkin's lymphoma: the old and the new.
    Friedberg JW
    Semin Hematol; 2008 Jul; 45(3 Suppl 2):S2-6. PubMed ID: 18760706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient Leukemoid Reaction from T-Cell Large Granular Lymphocytes Post Autologous Stem Cell Transplant in a Patient Affected by Hodgkin Lymphoma.
    Duminuco A; Parisi M; Milone GA; Cupri A; Leotta S; Palumbo GA; Parrinello NL; Scuderi G; Triolo A; Milone G
    Hematol Rep; 2023 Oct; 15(4):555-561. PubMed ID: 37873793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treg depletion supercharges ASCT power.
    Bruns H
    Blood; 2024 Apr; 143(16):1562-1563. PubMed ID: 38635248
    [No Abstract]   [Full Text] [Related]  

  • 10. Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure.
    Jiménez-Ubieto A; Grande C; Caballero D; Yáñez L; Novelli S; Hernández-Garcia MT; Manzanares M; Arranz R; Ferreiro JJ; Bobillo S; Mercadal S; Galeo A; López Jiménez J; Moraleda JM; Vallejo C; Albo C; Pérez E; Marrero C; Magnano L; Palomera L; Jarque I; Martínez-Sánchez P; Martín A; Coria E; López-Guillermo A; Salar A; Lahuerta JJ
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1631-1640. PubMed ID: 28533060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Is Different in Acute Hematologic Malignancy-Associated ARDS? An Overview of the Literature.
    Cotorogea-Simion M; Pavel B; Isac S; Telecan T; Matache IM; Bobirca A; Bobirca FT; Rababoc R; Droc G
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143892
    [No Abstract]   [Full Text] [Related]  

  • 12. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
    Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
    Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo purging and relapse prevention following ASCT.
    Gisselbrecht C
    Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S5-9. PubMed ID: 11840154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma.
    Berinstein NL; Buckstein R; Imrie K; Spaner D; Mangel J; Tompkins K; Pennell N; Reis M; Pavlin P; Lima A; Couvadia A; Robinson J; Richardson P
    Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S14-7. PubMed ID: 11840156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab: enhancing stem cell transplantation in mantle cell lymphoma.
    Gianni AM; Cortelazzo S; Magni M; Martelli M;
    Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S10-3. PubMed ID: 11840155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
    Nademanee A; Forman SJ
    Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma.
    Pettengell R
    Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S1-4. PubMed ID: 11840153
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.